Silver Point Capital, 10% Owner: Keenova Therapeutics Buy · Filed 05/21

Trade details

Type: Insider buy
Amount: $16,968,750
Shares · price: 187,500 sh · $90.50 a share
Held after: 5,825,214 sh
Stock: Keenova Therapeutics
Person: Silver Point Capital10% Owner
Trade date: 26/05/19
Filed: 26/05/21
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 3 insiders
Holding change: +3.3%

Keenova Therapeutics trades, last 26 weeks

Silver Point Capital's recent trades

Silver Point Capital10% Stockholder
Planned saleQVC Group
Planned sale
QVC Group
QVCG
$11.8M
720,000 sh
$11.8M
Filed 09/03
Traded 09/03
Silver Point Capital10% Stockholder
Planned saleQVC Group
Planned sale
QVC Group
QVCG
$875K
50,000 sh
$875K
Filed 08/11
Traded 08/11
Silver Point Capital10% Owner
BuyKeenova Therapeutics
Buy
Keenova Therapeutics
$19M
210,000 sh
$19M
Filed 05/21
Traded 05/20
Silver Point Capital10% Owner
BuyKeenova Therapeutics
Buy
Keenova Therapeutics
$37.1M
410,000 sh
$37.1M
Filed 04/17
Traded 04/17
Silver Point Capital10% Owner
BuyKeenova Therapeutics
Buy
Keenova Therapeutics
$24.3M
275,000 sh
$24.3M
Filed 04/17
Traded 04/15